event tracking

Hui Shen

24 results.

May 9, 2017 Research brief: New understanding of lethal women’s cancer

TCGA publishes molecular profile of uterine carcinosarcoma, offers potential new treatment options Researchers from The Cancer Genome Atlas, including Van Andel…

November 16, 2016 Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis

GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from the National Cancer…

November 15, 2016 Van Andel Institute hosts event highlighting women’s health: Experts share information, insight on women’s cancer

GRAND RAPIDS, Mich. (Nov. 16, 2016)—Van Andel Institute (VAI) today held “A Conversation About Women’s Health Hosted by Carol Van Andel: Common Cancers Affecting Women,”…

November 13, 2016 Endometrial cancer: Key facts

In the United States, endometrial cancer (which originates in the lining of the uterus) is the most common cancer of the female reproductive organs, and…

VAI DEFAULT HEADER
November 9, 2016 10 facts about ovarian cancer

As we gear up for next week’s luncheon, A Conversation About Women’s Health Hosted by Carol Van Andel, here are 10 facts about

November 17, 2015 Van Andel Research Institute’s Hui Shen receives ovarian cancer research award

GRAND RAPIDS, Mich. (Nov. 18, 2015)—The Ovarian Cancer Research Fund (OCRF) announced yesterday that Van Andel Research Institute (VARI)

November 4, 2015 TCGA findings provide molecular background for second most common kidney cancer

GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…

VAI DEFAULT HEADER
September 1, 2014 Van Andel Research Institute names new assistant professor as part of epigenetics expansion

Grand Rapids, Mich. (Sept. 2, 2014) –  Van Andel Research Institute (VARI) has added to its rapidly expanding epigenetics hub with the appointment of Hui Shen,…